Covishield third dose works against Omicron, says Oxford stu

AstraZeneca’s Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose booster, according to data from a new laboratory study

Related Keywords

Astrazeneca Vaxzevria , , Covishield , Covishield Third Dose , Omicron , Oxford Study ,